Fig. 2: List of survey terms in a tailored PRO-CTCAE survey for phase I trial cancer patients. | British Journal of Cancer

Fig. 2: List of survey terms in a tailored PRO-CTCAE survey for phase I trial cancer patients.

From: A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events

Fig. 2

30 terms corresponding to 58 potential survey items are included in the tailored survey. Attribute questions to be included for each term are denoted in superscript (F frequency, I interference, P presence, S severity). Frequency, interference, and severity questions are scored from 0–4 as per the full length PRO-CTCAE whereas presence/absence questions are scored from 0–1.

Back to article page